Marius C. Hoener

Dikutip oleh

	Semua	Sejak 2020
Kutipan	9875	4772
indeks-h	53	36
indeks-i10	91	78

1100

550

275

825

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202538 30 31 27 35 74 93 100 98 110 163 204 267 307 494 612 577 801 792 770 1003 1055 903 890 150

Akses publik

Lihat semua

39 artikel

2 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

Matthias LiechtiUniversity Hospital BaselEmail yang diverifikasi di usb.ch
Raul R. GainetdinovInstitute of Translational Biomedicine St. Petersburg State UniversityEmail yang diverifikasi di spbu.ru
Dino LuethiUniversity Hospital BaselEmail yang diverifikasi di usb.ch
Linda D. SimmlerAssistant Professor, University of Basel, Dpt. of Pharmaceutical SciencesEmail yang diverifikasi di unibas.ch
Tom KilduffCenter Director, Center for Neuroscience, SRI InternationalEmail yang diverifikasi di sri.com
Bernhard BettlerUniversity BaselEmail yang diverifikasi di unibas.ch
Mark D. BerryProfessor and Head, Biochemistry, Memorial University of NewfoundlandEmail yang diverifikasi di mun.ca
Stefano EspinozaPostdoc, Italian Institute of TechnologyEmail yang diverifikasi di iit.it
Ilya SukhanovFirst Pavlov State Medical Univercity of Saint PetersburgEmail yang diverifikasi di iit.it
Damiana LeoMons UniversityEmail yang diverifikasi di iit.it
Joerg HuwylerUniversity of BaselEmail yang diverifikasi di unibas.ch
Tanya WallaceVP, Translational Science, Neumora TherapeuticsEmail yang diverifikasi di neumoratx.com
Juan J. CanalesProfessor, Head of School, Victoria University of Wellington, New ZealandEmail yang diverifikasi di vuw.ac.nz
Stephan KrähenbühlClinical Pharmacology & Toxicology, Basel, SwitzerlandEmail yang diverifikasi di uhbs.ch
Marc G. CaronJames B. Duke Professor, Cell Biology, Medicine, Neurobiology Duke UniversityEmail yang diverifikasi di duke.edu
Fabio FumagalliUniversità Degli Studi di MilanoEmail yang diverifikasi di unimi.it
Lucia caffinoUniversity of MilanEmail yang diverifikasi di unimi.it
Eero CastrénNeuroscience Center, University of Helsinki, FinlandEmail yang diverifikasi di helsinki.fi
Tomi RantamäkiProfessorEmail yang diverifikasi di helsinki.fi
Antonio FerragudUniversity of CambridgeEmail yang diverifikasi di cam.ac.uk

Ikuti

Marius C. Hoener

Ph.D., Distinguished Scientist, Drug Discovery Project Team Leader

Email yang diverifikasi di roche.com

Neurodegenerative Disorders Psychiatry Drug Discovery Neuropsychopharmacology Rare diseases


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
Pharmacological characterization of designer cathinones in vitro LD Simmler, TA Buser, M Donzelli, Y Schramm, LH Dieu, J Huwyler, ... British journal of pharmacology 168 (2), 458-470, 2013	770	2013
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity FG Revel, JL Moreau, RR Gainetdinov, A Bradaia, TD Sotnikova, R Mory, ... Proceedings of the national academy of sciences 108 (20), 8485-8490, 2011	382	2011
Trace amine-associated receptor 1 modulates dopaminergic activity L Lindemann, CA Meyer, K Jeanneau, A Bradaia, L Ozmen, ... The Journal of pharmacology and experimental therapeutics 324 (3), 948-956, 2008	372	2008
Trace amines and their receptors RR Gainetdinov, MC Hoener, MD Berry Pharmacological reviews 70 (3), 549-620, 2018	370	2018
A renaissance in trace amines inspired by a novel GPCR family L Lindemann, MC Hoener Trends in pharmacological sciences 26 (5), 274-281, 2005	362	2005
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens A Rickli, OD Moning, MC Hoener, ME Liechti European Neuropsychopharmacology 26 (8), 1327-1337, 2016	357	2016
Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors L Lindemann, M Ebeling, NA Kratochwil, JR Bunzow, DK Grandy, ... Genomics 85 (3), 372-385, 2005	325	2005
Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of α-synuclein, parkin, and DJ-1 in Caenorhabditis elegans R Ved, S Saha, B Westlund, C Perier, L Burnam, A Sluder, M Hoener, ... Journal of Biological Chemistry 280 (52), 42655-42668, 2005	305	2005
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic-and antidepressant-like activity, improve cognition and control body weight FG Revel, JL Moreau, B Pouzet, R Mory, A Bradaia, D Buchy, V Metzler, ... Molecular psychiatry 18 (5), 543-556, 2013	297	2013
The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system A Bradaia, G Trube, H Stalder, RD Norcross, L Ozmen, JG Wettstein, ... Proceedings of the National Academy of Sciences 106 (47), 20081-20086, 2009	264	2009
Caenorhabditis elegans MPP⁺ Model of Parkinson’s Disease for High-Throughput Drug Screenings E Braungart, M Gerlach, P Riederer, R Baumeister, MC Hoener Neurodegenerative Diseases 1 (4-5), 175-183, 2004	252	2004
Monoamine transporter and receptor interaction profiles of a new series of designer cathinones LD Simmler, A Rickli, MC Hoener, ME Liechti Neuropharmacology 79, 152-160, 2014	246	2014
Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges MD Berry, RR Gainetdinov, MC Hoener, M Shahid Pharmacology & therapeutics 180, 161-180, 2017	239	2017
Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones A Rickli, MC Hoener, ME Liechti European Neuropsychopharmacology 25 (3), 365-376, 2015	221	2015
Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2, 5-dimethoxy-substituted phenethylamines (2C drugs) A Rickli, D Luethi, J Reinisch, D Buchy, MC Hoener, ME Liechti Neuropharmacology 99, 546-553, 2015	219	2015
Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats D Leo, I Sukhanov, F Zoratto, P Illiano, L Caffino, F Sanna, G Messa, ... Journal of Neuroscience 38 (8), 1959-1972, 2018	206	2018
The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (“ecstasy”) in humans CM Hysek, LD Simmler, M Ineichen, E Grouzmann, MC Hoener, ... Clinical pharmacology & therapeutics 90 (2), 246-255, 2011	205	2011
Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study CM Hysek, LD Simmler, VG Nicola, N Vischer, M Donzelli, S Krähenbühl, ... PloS one 7 (5), e36476, 2012	202	2012
Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics FG Revel, JL Moreau, RR Gainetdinov, A Ferragud, ... Biological psychiatry 72 (11), 934-942, 2012	184	2012
Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors D Leo, L Mus, S Espinoza, MC Hoener, TD Sotnikova, RR Gainetdinov Neuropharmacology 81, 283-291, 2014	153	2014

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama